摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(5-O-acetyl-2,3-dideoxy-3-fluoro-β-D-erythro-pentofuranosyl)-2-thiothymine | 1207863-30-6

中文名称
——
中文别名
——
英文名称
1-(5-O-acetyl-2,3-dideoxy-3-fluoro-β-D-erythro-pentofuranosyl)-2-thiothymine
英文别名
1-(5-0-acetyl-2,3-dideoxy-3-fluoro-β-D-ribofuranosyl)-2-thiothymine;[(2R,3S,5R)-3-fluoro-5-(5-methyl-4-oxo-2-sulfanylidenepyrimidin-1-yl)oxolan-2-yl]methyl acetate
1-(5-O-acetyl-2,3-dideoxy-3-fluoro-β-D-erythro-pentofuranosyl)-2-thiothymine化学式
CAS
1207863-30-6
化学式
C12H15FN2O4S
mdl
——
分子量
302.327
InChiKey
SHRFKBNEPILDJI-IVZWLZJFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    100
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(5-O-acetyl-2,3-dideoxy-3-fluoro-β-D-erythro-pentofuranosyl)-2-thiothymine 作用下, 以 甲醇 为溶剂, 反应 2.0h, 以97%的产率得到1-(2,3-dideoxy-3-fluoro-β-D-erythro-pentofuranosyl)-2-thiothymine
    参考文献:
    名称:
    Thiated derivatives of 2′,3′-dideoxy-3′-fluorothymidine: Synthesis, in vitro anti-HIV-1 activity and interaction with recombinant drug resistant HIV-1 reverse transcriptase forms
    摘要:
    Various thiated analogues of thymine 2',3'-dideoxy-3'-fluoronucleoside (FLT) and their 5'-monophosphates and 5'-triphosphates were prepared with the use of modified multistep procedures. The thiated analogues of FLT and FLTMP were evaluated against the wild type and drug- and multidrug-resistant strains of HIV-1, using the replicative phenotyping format of the deCIPhR assay, and showed potent inhibition of drug-resistant HIV-1 strains at low cytotoxicity. Additionally, inhibition of recombinant drug resistant forms of reverse transcriptase from single and multiple HIV-1 mutants by the synthesized 5'-triphosphates was investigated. The strongest inhibition was observed for K103N and Delta 67 mutants and the most potent anti-HIV-1 activity against drug resistant strains and the lowest cytotoxicity was exerted by S(4)FLTMP and FLTMP which may be regarded as potential anti-HIV/AIDS agents. (C) 2011 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.antiviral.2011.05.012
  • 作为产物:
    参考文献:
    名称:
    Thiated derivatives of 2′,3′-dideoxy-3′-fluorothymidine: Synthesis, in vitro anti-HIV-1 activity and interaction with recombinant drug resistant HIV-1 reverse transcriptase forms
    摘要:
    Various thiated analogues of thymine 2',3'-dideoxy-3'-fluoronucleoside (FLT) and their 5'-monophosphates and 5'-triphosphates were prepared with the use of modified multistep procedures. The thiated analogues of FLT and FLTMP were evaluated against the wild type and drug- and multidrug-resistant strains of HIV-1, using the replicative phenotyping format of the deCIPhR assay, and showed potent inhibition of drug-resistant HIV-1 strains at low cytotoxicity. Additionally, inhibition of recombinant drug resistant forms of reverse transcriptase from single and multiple HIV-1 mutants by the synthesized 5'-triphosphates was investigated. The strongest inhibition was observed for K103N and Delta 67 mutants and the most potent anti-HIV-1 activity against drug resistant strains and the lowest cytotoxicity was exerted by S(4)FLTMP and FLTMP which may be regarded as potential anti-HIV/AIDS agents. (C) 2011 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.antiviral.2011.05.012
点击查看最新优质反应信息

文献信息

  • 2',3'-dideoxynucleoside pyrimidine compounds and carbocyclic analogs
    申请人:Max-Delbru/ ck-Centrum
    公开号:US05496935A1
    公开(公告)日:1996-03-05
    2',3'-dideoxynucleoside pyrimidine compounds and 2-thiothymidine carbocyclic derivatives with antiviral activity are disclosed. These compounds are expected to exhibit antiviral activity recognized for 2',3'-dideoxynucleoside compounds and analogs thereof.
    本发明揭示了具有抗病毒活性的2',3'-二去氧核苷嘧啶化合物和2-代胸腺嘧啶环烷衍生物。这些化合物预计会表现出与2',3'-二去氧核苷化合物及其类似物所认可的抗病毒活性相同的效果。
  • US5496935A
    申请人:——
    公开号:US5496935A
    公开(公告)日:1996-03-05
查看更多